LIP
UTHR icon

Lighthouse Investment Partners’s United Therapeutics UTHR Stock Holding History

Lighthouse Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
+10,000
New +$4.98M 0.21% 165
2024
Q2 		– Sell
-30,000
Closed -$6.89M – 543
2024
Q1 		$6.89M Buy
+30,000
New +$6.77M 0.32% 86

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Lighthouse Investment Partners's UTHR Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 3,500 shares — an estimated $1.74M sold.

Lighthouse Investment Partners first reported a position in UTHR in Q4 2022 and held it in 5 quarters. The position peaked at $6.73M in Q2 2024. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 3,500 United Therapeutics shares in Q1 2026, an estimated $1.74M.
  • Lighthouse Investment Partners first reported a position in United Therapeutics in Q4 2022 and held it in 5 quarters.
  • Lighthouse Investment Partners's United Therapeutics position peaked at $6.73M in Q2 2024.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.